HSCT for adults with immunodeficiencies.
作者信息
Rao Sridhar, Broglie Larisa
机构信息
Versiti Blood Research Institute.
Medical College of Wisconsin.
出版信息
Blood. 2022 Oct 6;140(14):1580-1581. doi: 10.1182/blood.2022016422.
Abstract
摘要
相似文献
1
HSCT for adults with immunodeficiencies.针对免疫缺陷成人的造血干细胞移植
Blood. 2022 Oct 6;140(14):1580-1581. doi: 10.1182/blood.2022016422.
2
Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications.原发性免疫缺陷病的造血细胞移植：常规和新兴适应证。
Expert Rev Clin Immunol. 2018 Feb;14(2):103-114. doi: 10.1080/1744666X.2018.1424627. Epub 2018 Jan 16.
3
Advances in hematopoietic stem cell transplantation for primary immunodeficiency.原发性免疫缺陷造血干细胞移植的进展
Immunol Allergy Clin North Am. 2008 May;28(2):439-56, x-xi. doi: 10.1016/j.iac.2008.01.006.
4
Hematopoietic stem cell transplantation in Taiwanese children with primary immunodeficiency.台湾原发性免疫缺陷儿童的造血干细胞移植
J Formos Med Assoc. 2005 Feb;104(2):101-6.
5
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency.原发性免疫缺陷病的造血干细胞移植：超越严重联合免疫缺陷。
J Pediatric Infect Dis Soc. 2018 Dec 26;7(suppl_2):S79-S82. doi: 10.1093/jpids/piy114.
6
[Hematopoietic stem cell transplantation in children with primary immunodeficiencies].[原发性免疫缺陷患儿的造血干细胞移植]
Acta Med Croatica. 2009 Jun;63(3):255-8.
7
Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: a retrospective study.原发性免疫缺陷接受造血细胞移植的儿童口腔黏膜炎的危险因素：一项回顾性研究。
Pediatr Transplant. 2013 Aug;17(5):492-7. doi: 10.1111/petr.12094. Epub 2013 Jun 10.
8
Hematopoietic Stem Cell Transplant for Immune Deficiency and Immune Dysregulation Disorders.用于免疫缺陷和免疫失调疾病的造血干细胞移植
Immunol Allergy Clin North Am. 2015 Nov;35(4):695-711. doi: 10.1016/j.iac.2015.07.010. Epub 2015 Sep 4.
9
Post-Transplant CD34 Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies.移植后 CD34 选择的干细胞“增强”对原发性免疫缺陷儿童和年轻成人接受低强度预处理的造血干细胞移植后混合嵌合体。
Biol Blood Marrow Transplant. 2018 Jul;24(7):1527-1529. doi: 10.1016/j.bbmt.2018.03.013. Epub 2018 Mar 16.
10
Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders.原发性免疫缺陷病造血细胞移植进展更新。
Immunol Allergy Clin North Am. 2019 Feb;39(1):113-128. doi: 10.1016/j.iac.2018.08.003. Epub 2018 Nov 1.
引用本文的文献
1
Inborn errors of immunity in adulthood.成人期遗传性免疫缺陷病。
Allergy Asthma Clin Immunol. 2024 Jan 17;20(1):6. doi: 10.1186/s13223-023-00862-8.
本文引用的文献
1
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.青少年和成人遗传性免疫缺陷患者的造血干细胞移植：一项欧洲血液与骨髓移植学会免疫缺陷工作组的研究
Blood. 2022 Oct 6;140(14):1635-1649. doi: 10.1182/blood.2022015506.
2
EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.欧洲血液与骨髓移植学会/国际原发性免疫缺陷病学会先天性免疫缺陷病造血干细胞移植工作小组指南
Bone Marrow Transplant. 2021 Sep;56(9):2052-2062. doi: 10.1038/s41409-021-01378-8. Epub 2021 Jul 5.
3
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.造血细胞移植治疗 Wiskott-Aldrich 综合征的优异结果：PIDTC 报告。
Blood. 2020 Jun 4;135(23):2094-2105. doi: 10.1182/blood.2019002939.
4
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.造血细胞移植和免疫效应细胞治疗的适应证：美国移植和细胞治疗学会指南。
Biol Blood Marrow Transplant. 2020 Jul;26(7):1247-1256. doi: 10.1016/j.bbmt.2020.03.002. Epub 2020 Mar 9.
5
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.慢性肉芽肿病相关炎症性肠病在异基因造血干细胞移植后缓解，且不会对生存造成不利影响。
J Clin Immunol. 2019 Oct;39(7):653-667. doi: 10.1007/s10875-019-00659-8. Epub 2019 Aug 2.
6
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.血液系统疾病、实体瘤和免疫紊乱的造血干细胞移植指征：2019年欧洲的当前实践
Bone Marrow Transplant. 2019 Oct;54(10):1525-1552. doi: 10.1038/s41409-019-0516-2. Epub 2019 Apr 5.
7
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.造血干细胞移植合并症指数预测非恶性疾病异基因移植后的生存。
Blood. 2019 Feb 14;133(7):754-762. doi: 10.1182/blood-2018-09-876284. Epub 2018 Dec 13.
8
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.成人原发性免疫缺陷症患者接受异基因造血干细胞移植后获得成功。
Blood. 2018 Feb 22;131(8):917-931. doi: 10.1182/blood-2017-09-807487. Epub 2017 Dec 26.
9
Allogeneic stem cell transplantation in adolescents and young adults with primary immunodeficiencies.青少年和年轻成人原发性免疫缺陷患者的异基因干细胞移植
J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):298-301.e2. doi: 10.1016/j.jaip.2017.07.045. Epub 2017 Sep 22.
10
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency.多中心造血干细胞移植治疗常见变异性免疫缺陷严重并发症的经验
J Allergy Clin Immunol. 2015 Apr;135(4):988-997.e6. doi: 10.1016/j.jaci.2014.11.029. Epub 2015 Jan 14.
Zotero 插件